Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

ClinicalTrials.gov ID: NCT00078338

Public ClinicalTrials.gov record NCT00078338. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 5:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase IV, Multicenter, Open Label, Randomized Study of Rebif® 44 mcg Administered Three Times Per Week by Subcutaneous Injection Compared With Copaxone® 20 mg Administered Daily by Subcutaneous Injection in the Treatment of Relapsing Remitting Multiple Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to assess the clinical efficacy of Rebif® 44 microgram (mcg) three times per week compared with Copaxone® 20 milligram (mg) daily in subjects with relapsing Multiple Sclerosis.

Study identification

NCT ID
NCT00078338
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
EMD Serono
Industry
Enrollment
764 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2004 (Actual)
Primary completion
Nov 28, 2006 (Actual)
Completion
Nov 28, 2006 (Actual)
Last update posted
Jun 27, 2018

2004 – 2006

United States locations

U.S. sites
41
U.S. states
25
U.S. cities
39
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249 —
Barrow Neurology Clinics Phoenix Arizona 85013 —
Northwest NeuroSpecialists Tucson Arizona 85741 —
University of California, Davis Sacramento California 95817 —
Kaiser Permanente Neurology San Diego California 92102 —
Advanced Neurology of Colorado, LLC Fort Collins Colorado 80528 —
The MS Treatment Center at Griffin Hospital Derby Connecticut 06418 —
Associated Neurologists of Southern Connecticut, P.C. Fairfield Connecticut 06824 —
Neurological Center of South Florida Miami Florida 33176 —
Harbourside Medical Plaza Tampa Florida 33606 —
Shepherd Center Atlanta Georgia 30309 —
University Chicago Hospitals Chicago Illinois 60619 —
Consultants In Neurology, Ltd. Northbrook Illinois 60062 —
Fort Wayne Neurological Center Fort Wayne Indiana 46805 —
University of Maryland MD Center for MS Baltimore Maryland 21201 —
University Of Michigan Ann Arbor Michigan 48109 —
Wayne State University Detroit Michigan 48201 —
Henry Ford Hospital Dept of Neurology Detroit Michigan 48202 —
The Minneapolis Clinic of Neurology Golden Valley Minnesota 55422 —
University of Minnesota Medical School, Dept of Neurology Minneapolis Minnesota 55455 —
Nevada Neurological Consultants Henderson Nevada 89052 —
Albany Medical College Dept of Neurology MC-70 Albany New York 12208 —
Neurology University of Rochester Rochester New York 14642 —
SUNY At Stony Brook U Hospital - Department of Neurology Stony Brook New York 11794 —
SUNY Upstate Medical University Dept of Neurology Syracuse New York 13210 —
MS Center/CHS Charlotte North Carolina 28207 —
Wake Forest Univ. Health Sciences Winston-Salem North Carolina 27157 —
Ohio State University Columbus Ohio 43210 —
Oak Clinic for Multiple Sclerosis Uniontown Ohio 44685 —
Medford Neurological and Spine Clinic Medford Oregon 97504 —
University Of Pennsylvania Philadelphia Pennsylvania 19104 —
Thomas Jefferson University Physicians Dept of Neurology Philadelphia Pennsylvania 19107 —
Baptist West Hospital Knoxville Tennessee 37922 —
University of Texas-Houston Houston Texas 77030 —
Central Texas Neurology Round Rock Texas 78681 —
Neurology Health Care Service / Fletcher Allen Health Care Burlington Vermont 05401 —
Neurology Center of Fairfax Fairfax Virginia 22031 —
Blue Ridge Research Center Roanoke Virginia 24014 —
Minor & James Medical, PLLC Seattle Washington 98104 —
CAMC Institute Charleston West Virginia 25304 —
Center for Neurological Disorders Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00078338, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 27, 2018 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00078338 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →